Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.
about
Biopharmaceuticals and monoclonal antibodies in oncology trials--a cross-sectional analysisTherapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis.Review on modeling anti-antibody responses to monoclonal antibodies.Simplification of complex physiologically based pharmacokinetic models of monoclonal antibodies.Impaired resolution of DSS-induced colitis in mice lacking the glucocorticoid receptor in myeloid cells.CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.
P2860
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Current status of monoclonal a ...... of inflammatory bowel disease.
@ast
Current status of monoclonal a ...... of inflammatory bowel disease.
@en
Current status of monoclonal a ...... of inflammatory bowel disease.
@nl
type
label
Current status of monoclonal a ...... of inflammatory bowel disease.
@ast
Current status of monoclonal a ...... of inflammatory bowel disease.
@en
Current status of monoclonal a ...... of inflammatory bowel disease.
@nl
prefLabel
Current status of monoclonal a ...... of inflammatory bowel disease.
@ast
Current status of monoclonal a ...... of inflammatory bowel disease.
@en
Current status of monoclonal a ...... of inflammatory bowel disease.
@nl
P2860
P356
P1476
Current status of monoclonal a ...... of inflammatory bowel disease.
@en
P2093
Brijen Shah
Lloyd Mayer
P2860
P304
P356
10.1586/ECI.10.45
P577
2010-07-01T00:00:00Z